CLINICAL_TRIALS
trial_result
· 2018-01-30
Clinical Trial Update: Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 trial update for BI 695500 in rheumatoid arthritis; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: TERMINATED | Results posted: 2018-01-30